Principal Technologies (TSXV:PTEC) Research & Development: C$0.59 Mil (TTM As of Jan. 2026)


TSXV:PTEC Principal Technologies Inc TSXV:PTEC
22 GF Score
Price C$0.38
GF Value C$0.03
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Principal Technologies Research & Development?

Principal Technologies TSXV:PTEC 22 Research & Development is C$0.59 Mil as of Jan. 2026. GuruFocus rates TSXV:PTEC with a GF Score™ of 22/100 and a GF Value™ of C$0.03 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Principal Technologies's Research & Development for the three months ended in Jan. 2026 was C$0.18 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 was C$0.59 Mil.

Principal Technologies  (TSXV:PTEC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Principal Technologies Research & Development Related Terms

Principal Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for Principal Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Principal Technologies Research & Development Chart

Principal Technologies Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.28

Principal Technologies Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.17 0.11 0.14 0.18
TSXV:PTEC
22GF Score
Principal Technologies Inc TSXV:PTEC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Principal Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of C$0.59 Mil mean?
Principal Technologies (TSXV:PTEC) has a Research & Development of C$0.59 Mil as of Jan. 2026. Research and development expense is the total cost for research and development activities. View historical data on Principal Technologies and its competitors.
Is Principal Technologies' Research & Development too high?
Principal Technologies' current Research & Development is C$0.59 Mil. Overall, Principal Technologies has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Principal Technologies' Research & Development compare to VEEV and BTSG?
Principal Technologies' Research & Development of C$0.59 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Principal Technologies and its competitors. Principal Technologies's current Research & Development is C$0.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Principal Technologies stock overvalued right now?
Based on GuruFocus' analysis, Principal Technologies (TSXV:PTEC) is currently considered Significantly Overvalued. The stock's GF Value™ is C$0.03, compared to a current price of C$0.38 — trading 1166.7% above its estimated fair value. The current Research & Development is C$0.59 Mil. Principal Technologies' overall GF Score™ is 22/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Principal Technologies (TSXV:PTEC), the current Research & Development is C$0.59 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Principal Technologies (TSXV:PTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Principal Technologies stock appears to be overvalued. The current stock price of C$0.38 is trading 1166.7% above its estimated GF Value™ of C$0.03. GuruFocus considers Principal Technologies to be Significantly Overvalued.

Key valuation signals for TSXV:PTEC:

  • Research & Development: C$0.59 Mil
  • GF Value™: C$0.03 vs. price of C$0.38 (1166.7% above fair value)
  • GF Score™: 22/100 with 7 warning signs

No single metric tells the full story. See the TSXV:PTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Principal Technologies Business Description

Other Exchanges JO7:Germany
Address 700 West Georgia Street, Suite 2500, Vancouver, BC, CAN, V7Y 1B3
Principal Technologies Inc is in the research and development stage of building a portfolio of medical technology assets with a focus on distribution potential and intellectual property capable of enhancing medical treatment, cost efficiency, and optimization of the patient pathway. The company focuses on acquiring medical technology research and development assets or developing them jointly with industry leaders. Its current revenue-generating activities are attributable to E&E CRO Consulting GmbH, which provides clinical research advisory services. The company operates in one reportable operational segment, consisting of project management of clinical studies and research related to medical device technologies.
22GF Score

Get the complete analysis for TSXV:PTEC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.38
Price
C$0.03
GF Value